Discontinuation report KIDROLASE

Last updated on 2021-09-01 History
Report ID 108355
Drug Identification Number 01926438
Brand name KIDROLASE
Common or Proper name L-asparaginase powder for solution
Company Name JAZZ PHARMACEUTICALS FRANCE SAS
Market Status CANCELLED POST MARKET
Active Ingredient(s) ASPARAGINASE
Strength(s) 10000UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 1 vial/pack
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for discontinuation Manufacturing issues
Anticipated discontinuation date 2020-11-10
Actual discontinuation date 2021-06-30
Remaining supply date 2020-02-29
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 84 QUAI CHARLES DE GAULLE CITY ONE
LYON, AUVERGNE-RHONE-ALPES
FRANCE 69006
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-09-01 French Compare
v5 2021-09-01 English Compare
v4 2021-09-01 English Compare
v3 2020-03-10 French Compare
v2 2020-03-10 English Compare
v1 2020-03-10 English Compare

Showing 1 to 6 of 6